Dear MedWatch Subscriber;
Please find attached a follow-up communication on the November 10, 2009 Dear Healthcare Professional letter from Dr. Margaret Hamburg, Commissioner of Food and Drugs. The letter updates the FDA/CDC experience with the H1N1 vaccination program and provides some detail on the current vaccine safety monitoring program.
We hope this information will be helpful to you as you manage and care for your patients during this influenza season.
The letter can also be viewed on FDA’s H1N1 website at
http://www.fda.gov/NewsEvents/PublicHealthFocus/ucm197733.htmManage your FDA Subscriptions:
- Update your preferences or unsubscribe
- Questions about this service? support@xxxxxxxxxxxxxxx
- Other inquiries? webmail@xxxxxxxxxx
GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420
Attachment:
commissioner_hamburg_dear_health_professional_letter_01-14-2010_locked.pdf
Description: Binary data